Skip to content

Prime Medicine PRME Total Revenue

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$19.8B+55.5%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.99B+7.8%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$15.05M-9.5%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$1.46M+68.6%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$31.74M+325%
Regenxbio logo
RegenxbioRGNX
$6.39M-92.8%

Segments

By segment

See full
Reportable Segment$856K-41.1%

Other financials

Income statement

See full
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Prime Medicine’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's total revenue?
Prime Medicine (PRME) reported total revenue of $838K in Q4 2025.
How has Prime Medicine's total revenue changed year-over-year?
Prime Medicine's total revenue decreased by 61.6% year-over-year, from $2.18M to $838K.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.